市場調査レポート

商品コード

1396946

エソテリック検査市場：タイプ別、技術別、エンドユーザー別：世界の機会分析と産業予測、2023年～2032年

Esoteric Testing Market By Type, By Technology, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日: 2023年10月31日 | 発行: Allied Market Research

| ページ情報: 英文 307 Pages | 納期: 2～3営業日

価格

PDF (Single User License)

USD 5,730 898,234円

レポートPDFを1つのPCでご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回だけ可能です。印刷したレポートの利用もPDFのライセンス保持者になります。回覧のための複製も原則NGです。

PDF (5-user License)

USD 6,450 1,011,102円

レポートPDFを5名でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回可能です。印刷したレポートの利用もPDFのライセンス保持者5名となります。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,600 1,504,896円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

エソテリック検査市場は2022年に242億米ドルと評価され、2023年から2032年までのCAGRは11.0%を示し、2032年には685億米ドルに達すると推定されます。

エソテリック検査は、ルーチンの臨床検査室では実施されない希少分子の分析として定義されます。この分析は、リアルタイムポリメラーゼ連鎖反応、酵素結合免疫吸着アッセイ、フローサイトメトリー、DNAシーケンシングなど、さまざまな技術を用いて行われます。これらの検査には特殊な装置が必要で、小規模に行われます。これらの検査を実施し、様々な化学薬品や高度な機器を用いて結果を分析するには、熟練した人材が必要です。エソテリック検査は一般的に、希少疾患、感染症、内分泌疾患の診断のために実施されます。

エソテリック検査市場の成長は、がん、高血圧、糖尿病、慢性感染症などの慢性疾患の有病率の増加、早期疾患診断の重要性に対する意識の高まり、新しい検査の発売の増加によって大きく牽引されています。エソテリック検査は、がんやHIVなどの慢性疾患のより正確な診断と予後を可能にするために、特定のマーカーを検出するように設計されています。例えば、米国がん協会（ACS）によると、2022年には米国で新たに約190万人のがん患者が診断されると予想されています。このように、慢性疾患の有病率の増加は、専門的で難解な検査の需要を促進します。

さらに、一般の人々の間で病気の早期診断に対する意識が高まっていることも、難解な検査に対する需要を高めています。啓発キャンペーン、教育セミナー、研修プログラムは、早期疾病診断の重要性を強調しています。例えば、F. Hoffmann-La Roche Ltd.は、がん、肝炎、結核、HIV、HPV、心血管疾患、糖尿病などの疾患のスクリーニング・プログラムやカウンセリング・プログラムを実施するために、地域社会のパートナーを支援しています。さらに、技術の進歩や新製品の発売が市場の成長をさらに後押ししています。例えば、世界のライフサイエンス企業であるLaboratory Corporation of America Holdingsは、神経変性と神経細胞傷害の直接的な証拠を提供する新しいニューロフィラメント軽鎖（NfL）血液検査を発売しました。この検査により、医師は神経変性疾患の徴候を特定し、確認することができるようになります。

しかし、エソテリック検査に伴う高コストと熟練した検査技師の不足が、予測期間中の市場成長の妨げになると予想されます。一方、診断検査数の増加やDNAシーケンシングの技術的進歩は、予測期間中に市場成長の有利な機会を生み出すと予想されます。

市場の定義と範囲
主な調査結果
- 影響要因
- 主な投資機会
ポーターのファイブフォース分析
市場力学
- 促進要因
  - 慢性疾患および感染症の増加
  - 疾患の早期診断と個別化医療に対する意識の高まり
  - 医療検査機関数の増加
- 抑制要因
  - 難解な検査の高コスト
- 機会
  - エソテリック検査の技術的進歩

第4章エソテリック検査市場：タイプ別

概要
感染症検査
腫瘍学検査
内分泌学検査
遺伝子検査
毒物学検査
免疫学検査
神経学検査
その他の検査

第5章エソテリック検査市場：技術別

概要
酵素結合免疫吸着測定法
化学発光免疫測定法
質量分析法
リアルタイムポリメラーゼ連鎖反応
DNAシーケンス
フローサイトメトリー
その他の技術

第6章エソテリック検査市場：エンドユーザー別

概要
病院ベースの検査室
独立系検査機関・リファレンス検査機関

第7章エソテリック検査市場：地域別

概要
北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- その他
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- その他
ラテンアメリカ・中東・アフリカ
- ブラジル
- サウジアラビア
- 南アフリカ
- その他

第8章競争情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合ヒートマップ
主要企業のポジショニング、2022年

第9章企業プロファイル

Laboratory Corporation of America Holdings
ARUP Laboratories
Mayo Foundation for Medical Education and Research
Healius Limited
Opko Health, Inc.
Quest Diagnostics Inc.
Sonic Healthcare Limited
F. Hoffmann-La Roche Ltd.
Stanford Health Care
Athena Esoterix, LLC.

図表

LIST OF TABLES

TABLE 01. GLOBAL ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 02. ESOTERIC TESTING MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 03. ESOTERIC TESTING MARKET FOR ONCOLOGY TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 04. ESOTERIC TESTING MARKET FOR ENDOCRINOLOGY TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 05. ESOTERIC TESTING MARKET FOR GENETIC TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 06. ESOTERIC TESTING MARKET FOR TOXICOLOGY TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 07. ESOTERIC TESTING MARKET FOR IMMUNOLOGY TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 08. ESOTERIC TESTING MARKET FOR NEUROLOGY TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 09. ESOTERIC TESTING MARKET FOR OTHER TESTINGS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. GLOBAL ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 11. ESOTERIC TESTING MARKET FOR ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2022-2032 ($MILLION)
TABLE 12. ESOTERIC TESTING MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2022-2032 ($MILLION)
TABLE 13. ESOTERIC TESTING MARKET FOR MASS SPECTROMETRY, BY REGION, 2022-2032 ($MILLION)
TABLE 14. ESOTERIC TESTING MARKET FOR REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2022-2032 ($MILLION)
TABLE 15. ESOTERIC TESTING MARKET FOR DNA SEQUENCING, BY REGION, 2022-2032 ($MILLION)
TABLE 16. ESOTERIC TESTING MARKET FOR FLOW CYTOMETRY, BY REGION, 2022-2032 ($MILLION)
TABLE 17. ESOTERIC TESTING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022-2032 ($MILLION)
TABLE 18. GLOBAL ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 19. ESOTERIC TESTING MARKET FOR HOSPITAL-BASED LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 20. ESOTERIC TESTING MARKET FOR INDEPENDENT AND REFERENCE LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 21. ESOTERIC TESTING MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 22. NORTH AMERICA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 23. NORTH AMERICA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 24. NORTH AMERICA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 25. NORTH AMERICA ESOTERIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 26. U.S. ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 27. U.S. ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 28. U.S. ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. CANADA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 30. CANADA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 31. CANADA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 32. MEXICO ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 33. MEXICO ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 34. MEXICO ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 35. EUROPE ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 36. EUROPE ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 37. EUROPE ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 38. EUROPE ESOTERIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 39. GERMANY ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 40. GERMANY ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 41. GERMANY ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. FRANCE ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 43. FRANCE ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 44. FRANCE ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 45. UK ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 46. UK ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 47. UK ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. ITALY ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 49. ITALY ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 50. ITALY ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. SPAIN ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 52. SPAIN ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 53. SPAIN ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 54. REST OF EUROPE ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 55. REST OF EUROPE ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 56. REST OF EUROPE ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 57. ASIA-PACIFIC ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 58. ASIA-PACIFIC ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 59. ASIA-PACIFIC ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 60. ASIA-PACIFIC ESOTERIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 61. JAPAN ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 62. JAPAN ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 63. JAPAN ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 64. CHINA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 65. CHINA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 66. CHINA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. INDIA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 68. INDIA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 69. INDIA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 70. AUSTRALIA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 71. AUSTRALIA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 72. AUSTRALIA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 74. REST OF ASIA-PACIFIC ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 75. REST OF ASIA-PACIFIC ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 76. LAMEA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 77. LAMEA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 78. LAMEA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 79. LAMEA ESOTERIC TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 80. BRAZIL ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 81. BRAZIL ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 82. BRAZIL ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. SAUDI ARABIA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 84. SAUDI ARABIA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 85. SAUDI ARABIA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. SOUTH AFRICA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 87. SOUTH AFRICA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 88. SOUTH AFRICA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 89. REST OF LAMEA ESOTERIC TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 90. REST OF LAMEA ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 91. REST OF LAMEA ESOTERIC TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 92. LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY EXECUTIVES
TABLE 93. LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT
TABLE 94. LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCT SEGMENTS
TABLE 95. LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCT PORTFOLIO
TABLE 96. LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY STRATERGIES
TABLE 97. ARUP LABORATORIES: KEY EXECUTIVES
TABLE 98. ARUP LABORATORIES: COMPANY SNAPSHOT
TABLE 99. ARUP LABORATORIES: SERVICE SEGMENTS
TABLE 100. ARUP LABORATORIES: PRODUCT PORTFOLIO
TABLE 101. MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH: KEY EXECUTIVES
TABLE 102. MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH: COMPANY SNAPSHOT
TABLE 103. MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH: SERVICE SEGMENTS
TABLE 104. MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH: PRODUCT PORTFOLIO
TABLE 105. HEALIUS LIMITED: KEY EXECUTIVES
TABLE 106. HEALIUS LIMITED: COMPANY SNAPSHOT
TABLE 107. HEALIUS LIMITED: SERVICE SEGMENTS
TABLE 108. HEALIUS LIMITED: PRODUCT PORTFOLIO
TABLE 109. OPKO HEALTH, INC.: KEY EXECUTIVES
TABLE 110. OPKO HEALTH, INC.: COMPANY SNAPSHOT
TABLE 111. OPKO HEALTH, INC.: PRODUCT SEGMENTS
TABLE 112. OPKO HEALTH, INC.: PRODUCT PORTFOLIO
TABLE 113. OPKO HEALTH, INC.: KEY STRATERGIES
TABLE 114. QUEST DIAGNOSTICS INC.: KEY EXECUTIVES
TABLE 115. QUEST DIAGNOSTICS INC.: COMPANY SNAPSHOT
TABLE 116. QUEST DIAGNOSTICS INC.: SERVICE SEGMENTS
TABLE 117. QUEST DIAGNOSTICS INC.: PRODUCT PORTFOLIO
TABLE 118. QUEST DIAGNOSTICS INC.: KEY STRATERGIES
TABLE 119. SONIC HEALTHCARE LIMITED: KEY EXECUTIVES
TABLE 120. SONIC HEALTHCARE LIMITED: COMPANY SNAPSHOT
TABLE 121. SONIC HEALTHCARE LIMITED: SERVICE SEGMENTS
TABLE 122. SONIC HEALTHCARE LIMITED: PRODUCT PORTFOLIO
TABLE 123. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
TABLE 124. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 125. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
TABLE 126. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 127. STANFORD HEALTH CARE: KEY EXECUTIVES
TABLE 128. STANFORD HEALTH CARE: COMPANY SNAPSHOT
TABLE 129. STANFORD HEALTH CARE: SERVICE SEGMENTS
TABLE 130. STANFORD HEALTH CARE: PRODUCT PORTFOLIO
TABLE 131. ATHENA ESOTERIX, LLC.: KEY EXECUTIVES
TABLE 132. ATHENA ESOTERIX, LLC.: COMPANY SNAPSHOT
TABLE 133. ATHENA ESOTERIX, LLC.: SERVICE SEGMENTS
TABLE 134. ATHENA ESOTERIX, LLC.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. ESOTERIC TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF ESOTERIC TESTING MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN ESOTERIC TESTING MARKET
FIGURE 04. TOP INVESTMENT POCKETS IN ESOTERIC TESTING MARKET (2023-2032)
FIGURE 05. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTES
FIGURE 08. MODERATE INTENSITY OF RIVALRY
FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL ESOTERIC TESTING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. ESOTERIC TESTING MARKET, BY TYPE, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR ONCOLOGY TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR ENDOCRINOLOGY TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR GENETIC TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR TOXICOLOGY TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR IMMUNOLOGY TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR NEUROLOGY TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR OTHER TESTINGS, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. ESOTERIC TESTING MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR ENZYME-LINKED IMMUNOSORBENT ASSAY, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR MASS SPECTROMETRY, BY COUNTRY 2022 AND 2032(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR REAL TIME POLYMERASE CHAIN REACTION, BY COUNTRY 2022 AND 2032(%)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR DNA SEQUENCING, BY COUNTRY 2022 AND 2032(%)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR FLOW CYTOMETRY, BY COUNTRY 2022 AND 2032(%)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 28. ESOTERIC TESTING MARKET, BY END USER, 2022 AND 2032(%)
FIGURE 29. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR HOSPITAL-BASED LABORATORIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 30. COMPARATIVE SHARE ANALYSIS OF ESOTERIC TESTING MARKET FOR INDEPENDENT AND REFERENCE LABORATORIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 31. ESOTERIC TESTING MARKET BY REGION, 2022 AND 2032(%)
FIGURE 32. U.S. ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 33. CANADA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 34. MEXICO ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 35. GERMANY ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 36. FRANCE ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 37. UK ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 38. ITALY ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 39. SPAIN ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 40. REST OF EUROPE ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 41. JAPAN ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 42. CHINA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 43. INDIA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 44. AUSTRALIA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 45. REST OF ASIA-PACIFIC ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 46. BRAZIL ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 47. SAUDI ARABIA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 48. SOUTH AFRICA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 49. REST OF LAMEA ESOTERIC TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 50. TOP WINNING STRATEGIES, BY YEAR (2021-2023)
FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT (2021-2023)
FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY (2021-2023)
FIGURE 53. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 54. COMPETITIVE DASHBOARD
FIGURE 55. COMPETITIVE HEATMAP: ESOTERIC TESTING MARKET
FIGURE 56. TOP PLAYER POSITIONING, 2022
FIGURE 57. LABORATORY CORPORATION OF AMERICA HOLDINGS: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 58. LABORATORY CORPORATION OF AMERICA HOLDINGS: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 59. HEALIUS LIMITED: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 60. HEALIUS LIMITED: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 61. OPKO HEALTH, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 62. OPKO HEALTH, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 63. QUEST DIAGNOSTICS INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 64. QUEST DIAGNOSTICS INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 65. SONIC HEALTHCARE LIMITED: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 66. SONIC HEALTHCARE LIMITED: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 67. SONIC HEALTHCARE LIMITED: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 68. F. HOFFMANN-LA ROCHE LTD.: SALES REVENUE, 2020-2022 ($MILLION)
FIGURE 69. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 70. STANFORD HEALTH CARE: NET REVENUE, 2020-2022 ($MILLION)

Product Code: A12022

The esoteric testing market was valued at $24.2 billion in 2022 and is estimated to reach $68.5 billion by 2032, exhibiting a CAGR of 11.0% from 2023 to 2032. Esoteric testing is defined as the analysis of rare molecules that are not performed in routine clinical labs. This analysis is done by using various technologies such as real time polymerase chain reaction, enzyme linked immunosorbent assay, flow cytometry, and DNA sequencing. These tests require specialized equipment and are performed on a small scale. It requires skilled personnel to conduct these tests and analyze the result by using various chemical agents and sophisticated instruments. Esoteric testing is generally performed for the diagnosis of rare diseases, infectious diseases, and endocrine diseases.

The esoteric testing market growth is significantly driven by increase in the prevalence of chronic diseases such as cancer, hypertension, diabetes and chronic infectious diseases; surge in awareness about importance of early disease diagnosis; and increase in new test launches. Esoteric tests are designed to detect specific markers to enable more precise diagnosis and prognosis of chronic diseases such as cancer and HIV. For instance, according to American Cancer Society (ACS), about 1.9 million new cancer cases are expected to be diagnosed in the U.S. in 2022. Thus, rise in prevalence of chronic diseases drives the demand for specialized, esoteric tests.

Furthermore, surge in awareness about early disease diagnosis among the general population has increased the demand for esoteric testing. Awareness campaigns, educational seminars, and training programs emphasize the importance of early disease diagnosis. For instance, F. Hoffmann-La Roche Ltd., supports local community partners to run screening programs and counselling programs for diseases such as cancers, hepatitis, tuberculosis, HIV, HPV, cardiovascular disease and diabetes. Moreover, technological advancements and new product launches further drive the market growth. For instance, Laboratory Corporation of America Holdings, a global life sciences company, launched its new Neurofilament Light Chain (NfL) blood test that provides direct evidence of neurodegeneration and neuronal injury. This test will allow doctors to identify and verify signs of neurodegenerative diseases.

However, the high cost associated with esoteric testing and lack of skilled laboratory technicians are anticipated to hinder the market growth during the forecast period. On the other hand, increase in the number of diagnostic testing and technological advancements in DNA sequencing are expected to create lucrative opportunities for market growth during the forecast period.

The esoteric testing market is segmented into type, technology, end user, and region. By type, the market is categorized into infectious disease testing, oncology testing, endocrinology testing, genetic testing, toxicology testing, immunology testing, neurology testing, and other testing. By technology, the market is divided into enzyme-linked immunosorbent assay, chemiluminescence immunoassay, mass-spectrometry, real time polymerase chain reaction, DNA sequencing, flow cytometry, and other technologies. By end user, the market is bifurcated into hospital-based laboratories and independent & reference laboratories. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global esoteric testing market are Laboratory Corporation of America Holdings, ARUP Laboratories, Opko Health, Inc., Quest Diagnostics Inc., F. Hoffmann-La Roche Ltd., Mayo Foundation for Medical Education and Research, Stanford Health Care, Healius Limited, Athena Esoterix, LLC, and Sonic Healthcare Limited. Key players operating in the market have adopted product launch, collaboration, and product approval as key strategies to expand their market share and product portfolio.

Key Benefits for Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the esoteric testing market analysis from 2022 to 2032 to identify the prevailing esoteric testing market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the esoteric testing market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global esoteric testing market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
SWOT Analysis

Key Market Segments

By Type

Infectious Disease Testing
Oncology Testing
Endocrinology Testing
Genetic Testing
Toxicology Testing
Immunology Testing
Neurology Testing
Other Testings

By Technology

Enzyme-linked Immunosorbent Assay
Chemiluminescence Immunoassay
Mass Spectrometry
Real Time Polymerase Chain Reaction
DNA Sequencing
Flow Cytometry
Other Technologies

By End User

Hospital-based Laboratories
Independent and Reference Laboratories

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

ARUP Laboratories
Quest Diagnostics Inc.
F. Hoffmann-La Roche Ltd.
Stanford Health Care
Healius Limited
Laboratory Corporation of America Holdings
Opko Health, Inc.
Mayo Foundation for Medical Education and Research
Athena Esoterix, LLC.
Sonic Healthcare Limited

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. High bargaining power of suppliers
- 3.3.2. Moderate threat of new entrants
- 3.3.3. Moderate threat of substitutes
- 3.3.4. Moderate intensity of rivalry
- 3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Increase in prevalence of chronic and infectious diseases
  - 3.4.1.2. Increase in awareness about early disease diagnosis and personalized medicine
  - 3.4.1.3. Increase in number of medical laboratories
- 3.4.2. Restraints
  - 3.4.2.1. High cost of esoteric testing
- 3.4.3. Opportunities
  - 3.4.3.1. Technological advancements in esoteric testing

CHAPTER 4: ESOTERIC TESTING MARKET, BY TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Infectious Disease Testing
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Oncology Testing
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Endocrinology Testing
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
4.5. Genetic Testing
- 4.5.1. Key market trends, growth factors and opportunities
- 4.5.2. Market size and forecast, by region
- 4.5.3. Market share analysis by country
4.6. Toxicology Testing
- 4.6.1. Key market trends, growth factors and opportunities
- 4.6.2. Market size and forecast, by region
- 4.6.3. Market share analysis by country
4.7. Immunology Testing
- 4.7.1. Key market trends, growth factors and opportunities
- 4.7.2. Market size and forecast, by region
- 4.7.3. Market share analysis by country
4.8. Neurology Testing
- 4.8.1. Key market trends, growth factors and opportunities
- 4.8.2. Market size and forecast, by region
- 4.8.3. Market share analysis by country
4.9. Other Testings
- 4.9.1. Key market trends, growth factors and opportunities
- 4.9.2. Market size and forecast, by region
- 4.9.3. Market share analysis by country

CHAPTER 5: ESOTERIC TESTING MARKET, BY TECHNOLOGY

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Enzyme-linked Immunosorbent Assay
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Chemiluminescence Immunoassay
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Mass Spectrometry
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Real Time Polymerase Chain Reaction
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country
5.6. DNA Sequencing
- 5.6.1. Key market trends, growth factors and opportunities
- 5.6.2. Market size and forecast, by region
- 5.6.3. Market share analysis by country
5.7. Flow Cytometry
- 5.7.1. Key market trends, growth factors and opportunities
- 5.7.2. Market size and forecast, by region
- 5.7.3. Market share analysis by country
5.8. Other Technologies
- 5.8.1. Key market trends, growth factors and opportunities
- 5.8.2. Market size and forecast, by region
- 5.8.3. Market share analysis by country

CHAPTER 6: ESOTERIC TESTING MARKET, BY END USER

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Hospital-based Laboratories
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Independent and Reference Laboratories
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country

CHAPTER 7: ESOTERIC TESTING MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by Type
- 7.2.3. Market size and forecast, by Technology
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Market size and forecast, by Type
  - 7.2.5.1.2. Market size and forecast, by Technology
  - 7.2.5.1.3. Market size and forecast, by End User
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Market size and forecast, by Type
  - 7.2.5.2.2. Market size and forecast, by Technology
  - 7.2.5.2.3. Market size and forecast, by End User
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Market size and forecast, by Type
  - 7.2.5.3.2. Market size and forecast, by Technology
  - 7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by Type
- 7.3.3. Market size and forecast, by Technology
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Market size and forecast, by Type
  - 7.3.5.1.2. Market size and forecast, by Technology
  - 7.3.5.1.3. Market size and forecast, by End User
  - 7.3.5.2. France
  - 7.3.5.2.1. Market size and forecast, by Type
  - 7.3.5.2.2. Market size and forecast, by Technology
  - 7.3.5.2.3. Market size and forecast, by End User
  - 7.3.5.3. UK
  - 7.3.5.3.1. Market size and forecast, by Type
  - 7.3.5.3.2. Market size and forecast, by Technology
  - 7.3.5.3.3. Market size and forecast, by End User
  - 7.3.5.4. Italy
  - 7.3.5.4.1. Market size and forecast, by Type
  - 7.3.5.4.2. Market size and forecast, by Technology
  - 7.3.5.4.3. Market size and forecast, by End User
  - 7.3.5.5. Spain
  - 7.3.5.5.1. Market size and forecast, by Type
  - 7.3.5.5.2. Market size and forecast, by Technology
  - 7.3.5.5.3. Market size and forecast, by End User
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Market size and forecast, by Type
  - 7.3.5.6.2. Market size and forecast, by Technology
  - 7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by Type
- 7.4.3. Market size and forecast, by Technology
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. Japan
  - 7.4.5.1.1. Market size and forecast, by Type
  - 7.4.5.1.2. Market size and forecast, by Technology
  - 7.4.5.1.3. Market size and forecast, by End User
  - 7.4.5.2. China
  - 7.4.5.2.1. Market size and forecast, by Type
  - 7.4.5.2.2. Market size and forecast, by Technology
  - 7.4.5.2.3. Market size and forecast, by End User
  - 7.4.5.3. India
  - 7.4.5.3.1. Market size and forecast, by Type
  - 7.4.5.3.2. Market size and forecast, by Technology
  - 7.4.5.3.3. Market size and forecast, by End User
  - 7.4.5.4. Australia
  - 7.4.5.4.1. Market size and forecast, by Type
  - 7.4.5.4.2. Market size and forecast, by Technology
  - 7.4.5.4.3. Market size and forecast, by End User
  - 7.4.5.5. Rest of Asia-Pacific
  - 7.4.5.5.1. Market size and forecast, by Type
  - 7.4.5.5.2. Market size and forecast, by Technology
  - 7.4.5.5.3. Market size and forecast, by End User
7.5. LAMEA
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by Type
- 7.5.3. Market size and forecast, by Technology
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Brazil
  - 7.5.5.1.1. Market size and forecast, by Type
  - 7.5.5.1.2. Market size and forecast, by Technology
  - 7.5.5.1.3. Market size and forecast, by End User
  - 7.5.5.2. Saudi Arabia
  - 7.5.5.2.1. Market size and forecast, by Type
  - 7.5.5.2.2. Market size and forecast, by Technology
  - 7.5.5.2.3. Market size and forecast, by End User
  - 7.5.5.3. South Africa
  - 7.5.5.3.1. Market size and forecast, by Type
  - 7.5.5.3.2. Market size and forecast, by Technology
  - 7.5.5.3.3. Market size and forecast, by End User
  - 7.5.5.4. Rest of LAMEA
  - 7.5.5.4.1. Market size and forecast, by Type
  - 7.5.5.4.2. Market size and forecast, by Technology
  - 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

9.1. Laboratory Corporation of America Holdings
- 9.1.1. Company overview
- 9.1.2. Key executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
- 9.1.7. Key strategic moves and developments
9.2. ARUP Laboratories
- 9.2.1. Company overview
- 9.2.2. Key executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
9.3. Mayo Foundation for Medical Education and Research
- 9.3.1. Company overview
- 9.3.2. Key executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
9.4. Healius Limited
- 9.4.1. Company overview
- 9.4.2. Key executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
9.5. Opko Health, Inc.
- 9.5.1. Company overview
- 9.5.2. Key executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business performance
- 9.5.7. Key strategic moves and developments
9.6. Quest Diagnostics Inc.
- 9.6.1. Company overview
- 9.6.2. Key executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Business performance
- 9.6.7. Key strategic moves and developments
9.7. Sonic Healthcare Limited
- 9.7.1. Company overview
- 9.7.2. Key executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.7.6. Business performance
9.8. F. Hoffmann-La Roche Ltd.
- 9.8.1. Company overview
- 9.8.2. Key executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Business performance
9.9. Stanford Health Care
- 9.9.1. Company overview
- 9.9.2. Key executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Business performance
9.10. Athena Esoterix, LLC.
- 9.10.1. Company overview
- 9.10.2. Key executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio

エソテリック検査市場：タイプ別、技術別、エンドユーザー別：世界の機会分析と産業予測、2023年～2032年

Esoteric Testing Market By Type, By Technology, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章エソテリック検査市場：タイプ別

第5章エソテリック検査市場：技術別

第6章エソテリック検査市場：エンドユーザー別

第7章エソテリック検査市場：地域別

第8章競争情勢

第9章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

By Type

By Technology

By End User

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: ESOTERIC TESTING MARKET, BY TYPE

CHAPTER 5: ESOTERIC TESTING MARKET, BY TECHNOLOGY

CHAPTER 6: ESOTERIC TESTING MARKET, BY END USER

CHAPTER 7: ESOTERIC TESTING MARKET, BY REGION

CHAPTER 8: COMPETITIVE LANDSCAPE

CHAPTER 9: COMPANY PROFILES

エソテリック検査市場：タイプ別、技術別、エンドユーザー別：世界の機会分析と産業予測、2023年～2032年

Esoteric Testing Market By Type, By Technology, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

第4章 エソテリック検査市場：タイプ別

第5章 エソテリック検査市場：技術別

第6章 エソテリック検査市場：エンドユーザー別

第7章 エソテリック検査市場：地域別

第8章 競争情勢

第9章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

By Type

By Technology

By End User

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: ESOTERIC TESTING MARKET, BY TYPE

CHAPTER 5: ESOTERIC TESTING MARKET, BY TECHNOLOGY

CHAPTER 6: ESOTERIC TESTING MARKET, BY END USER

CHAPTER 7: ESOTERIC TESTING MARKET, BY REGION

CHAPTER 8: COMPETITIVE LANDSCAPE

CHAPTER 9: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章エソテリック検査市場：タイプ別

第5章エソテリック検査市場：技術別

第6章エソテリック検査市場：エンドユーザー別

第7章エソテリック検査市場：地域別

第8章競争情勢

第9章企業プロファイル